Mammalian target of rapamycin expression in poorly differentiated endocrine carcinoma: clinical and therapeutic future challenges.
about
Neuroendocrine Carcinomas of the Gastroenteropancreatic System: A Comprehensive ReviewPI3K-AKT-mTOR-signaling and beyond: the complex network in gastroenteropancreatic neuroendocrine neoplasmsGastroenteropancreatic high-grade neuroendocrine carcinomaEmerging approaches in the management of patients with neuroendocrine liver metastasis: role of liver-directed and systemic therapies.Prognostic significance of MTOR pathway component expression in neuroendocrine tumors.A case study of an integrative genomic and experimental therapeutic approach for rare tumors: identification of vulnerabilities in a pediatric poorly differentiated carcinoma.Chemotherapy for advanced poorly differentiated pancreatic neuroendocrine carcinoma.Suppression of mTOR pathway in solid tumors: lessons learned from clinical experience in renal cell carcinoma and neuroendocrine tumors and new perspectives.CXCR4/CXCL12/CXCR7 axis is functional in neuroendocrine tumors and signals on mTOR.Prolonged clinical benefit of everolimus therapy in the management of high-grade pancreatic neuroendocrine carcinoma.Are targeted therapies a consideration in poorly differentiated neuroendocrine tumors?Prognostic and predictive role of the PI3K-AKT-mTOR pathway in neuroendocrine neoplasms.
P2860
Q26768483-A3E976C1-A3E2-4D7F-B323-3F40978810C8Q26862544-8A0A1F9A-DD41-4F42-A197-B066064852F6Q26998392-4CB0C80C-4808-400A-B79D-D9C842C5DF60Q36512778-7B8FD01A-CE5A-45D0-91E8-466C54A56BF3Q37165103-44ABC199-4763-4D04-A926-DFB844D6D5DCQ37383599-E9AC312F-FFF2-42BF-B976-8383E31059A7Q38371367-530A233E-E7C0-4748-BC3D-0742CA696724Q38527936-083927BE-0BEB-4D8F-94DB-63E59A2C938EQ38789650-773FB737-E933-4AD4-BB2D-411A7E772C5FQ42588070-780DF749-A86E-45C4-A209-F669E099ED08Q42910796-83796E8B-386E-4EA1-8750-09E15D230F47Q47847243-E298C4CC-EEEC-4CFB-8940-4748A7E7989E
P2860
Mammalian target of rapamycin expression in poorly differentiated endocrine carcinoma: clinical and therapeutic future challenges.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Mammalian target of rapamycin ...... therapeutic future challenges.
@en
Mammalian target of rapamycin ...... therapeutic future challenges.
@nl
type
label
Mammalian target of rapamycin ...... therapeutic future challenges.
@en
Mammalian target of rapamycin ...... therapeutic future challenges.
@nl
prefLabel
Mammalian target of rapamycin ...... therapeutic future challenges.
@en
Mammalian target of rapamycin ...... therapeutic future challenges.
@nl
P2093
P2860
P1433
P1476
Mammalian target of rapamycin ...... therapeutic future challenges.
@en
P2093
Emilio Bajetta
Francesca Dominoni
Laura Catena
Monica Valente
Monika Ducceschi
Valentina Colonna
P2860
P2888
P356
10.1007/S11523-011-0171-Z
P577
2011-04-06T00:00:00Z